Dicerna Pharmaceuticals (NASDAQ:DRNA) Insider Buying and Selling Activity
Insider Ownership Percentage: 21.28%
Insider Buying and Selling by Quarter
Dicerna Pharmaceuticals (NASDAQ DRNA) Insider Trading History
| Transaction Date | Insider Name | Title | Buy/Sell | Number of Shares | Average Share Price | Total Transaction | Shares Held After Transaction | Details |
|---|
| 12/4/2019 | Adam Koppel | Director | Sell | 1,500,000 | $24.68 | $37,020,000.00 | | |
| 12/2/2019 | James B Weissman | COO | Sell | 20,000 | $26.00 | $520,000.00 | 34,704 | |
| 12/2/2019 | Peter Kolchinsky | Director | Sell | 137,176 | $24.98 | $3,426,656.48 | | |
| 11/29/2019 | Peter Kolchinsky | Director | Sell | 138,000 | $24.22 | $3,342,360.00 | | |
| 11/27/2019 | Peter Kolchinsky | Director | Sell | 368,700 | $24.04 | $8,863,548.00 | | |
| 11/25/2019 | John B. Green | CFO | Sell | 12,500 | $24.95 | $311,875.00 | | |
| 11/25/2019 | Peter Kolchinsky | Director | Sell | 361,200 | $24.06 | $8,690,472.00 | | |
| 11/21/2019 | Peter Kolchinsky | Director | Sell | 351,505 | $22.98 | $8,077,584.90 | | |
| 11/19/2019 | Bain Capital Life Sciences Inv | Major Shareholder | Sell | 1,750,000 | $22.03 | $38,552,500.00 | | |
| 11/19/2019 | James B Weissman | COO | Sell | 20,000 | $24.00 | $480,000.00 | 34,704 | |
| 11/19/2019 | Peter Kolchinsky | Director | Sell | 397,183 | $23.92 | $9,500,617.36 | | |
| 11/18/2019 | John B. Green | CFO | Sell | 12,500 | $21.05 | $263,125.00 | | |
| 11/14/2019 | James B Weissman | COO | Sell | 20,000 | $20.00 | $400,000.00 | 34,704 | |
| 11/14/2019 | John B. Green | CFO | Sell | 3,562 | $20.00 | $71,240.00 | | |
| 10/31/2019 | James B Weissman | COO | Sell | 15,000 | $18.00 | $270,000.00 | 29,704 | |
| 10/31/2019 | John B. Green | CFO | Sell | 12,500 | $18.00 | $225,000.00 | | |
| 8/23/2019 | James B Weissman | Insider | Sell | 14,680 | $13.07 | $191,867.60 | 9,800 | |
| 5/29/2019 | Bain Capital Life Sciences Inv | Director | Sell | 1,600,000 | $12.50 | $20,000,000.00 | | |
| 4/2/2019 | James B Weissman | Insider | Sell | 15,000 | $15.00 | $225,000.00 | 39,480 | |
| 11/6/2018 | Brian K Halak | Director | Sell | 335,000 | $13.33 | $4,465,550.00 | | |
| 11/1/2018 | Brian K Halak | Director | Sell | 564,300 | $13.66 | $7,708,338.00 | | |
| 10/30/2018 | Brian K Halak | Director | Sell | 245,096 | $13.92 | $3,411,736.32 | | |
| 9/5/2018 | James B Weissman | Insider | Sell | 2,301 | $17.50 | $40,267.50 | 26,781 | |
| 8/15/2018 | Dennis Langer | Director | Sell | 14,531 | $16.00 | $232,496.00 | 29,064 | |
| 5/9/2018 | James B Weissman | Insider | Sell | 10,000 | $15.00 | $150,000.00 | 19,800 | |
| 4/20/2018 | James B Weissman | Insider | Sell | 8,965 | $13.00 | $116,545.00 | 9,800 | |
| 3/19/2018 | James B Weissman | Insider | Sell | 1,035 | $13.00 | $13,455.00 | 18,765 | |
| 12/18/2017 | Bain Capital Life Sciences Inv | Director | Buy | 285,000 | $7.00 | $1,995,000.00 | | |
| 11/16/2016 | Dennis Langer | Director | Sell | 23,766 | $3.52 | $83,656.32 | 43,595 | |
| 11/15/2016 | Douglas Fambrough | CEO | Buy | 33,100 | $3.71 | $122,801.00 | | |
| 5/12/2016 | James B Weissman | Insider | Buy | 5,000 | $3.29 | $16,450.00 | 15,100 | |
| 11/25/2014 | James E Flynn | Insider | Sell | 321,965 | $11.36 | $3,657,522.40 | | |
| 11/7/2014 | James E Flynn | Insider | Sell | 214,164 | $9.05 | $1,938,184.20 | | |
| 10/15/2014 | James E Flynn | Insider | Sell | 117,778 | $10.86 | $1,279,069.08 | | |
| 10/14/2014 | James E Flynn | Major Shareholder | Sell | 36,115 | $11.02 | $397,987.30 | | |
| 10/10/2014 | James E Flynn | Major Shareholder | Sell | 30,214 | $12.13 | $366,495.82 | | |
| 2/4/2014 | James E Flynn | Insider | Buy | 1,000,000 | $15.00 | $15,000,000.00 | | |
| 2/4/2014 | Stephen J Hoffman | Director | Buy | 200,000 | $15.00 | $3,000,000.00 | | |
(Data available from 1/1/2013 forward)
